This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Novobiotic Pharmaceuticals, LLC. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Kelly Demeo: Innovator in Depsipeptide Research
Introduction
Kelly Demeo is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel depsipeptides. With a total of 2 patents to his name, Demeo's work is paving the way for new therapeutic approaches.
Latest Patents
Demeo's latest patents focus on the innovative uses of depsipeptides. The first patent details the preparation of novel depsipeptides and their pharmaceutical compositions. It also outlines methods for using these compounds to treat or inhibit various disorders. This groundbreaking research has the potential to impact the treatment landscape significantly.
Career Highlights
Kelly Demeo is currently associated with Novobiotic Pharmaceuticals, LLC, where he continues to advance his research. His work is characterized by a commitment to exploring the therapeutic potential of depsipeptides, which are gaining attention for their unique properties.
Collaborations
Demeo collaborates with esteemed colleagues, including Losee Lucy Ling and Kim Lewis. These partnerships enhance the research environment and contribute to the innovative outcomes of their projects.
Conclusion
In summary, Kelly Demeo is a prominent inventor whose work on depsipeptides is making strides in pharmaceutical research. His contributions are essential for the development of new treatments, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile